Revealing the inhibitory effect of VASH1 on ovarian cancer from multiple perspectives.
Ontology highlight
ABSTRACT: The function of Vasohibin-1 (VASH1) in human cancer has not been thoroughly or comprehensively examined. Here, we identified the tumor suppressor part of VASH1 across cancers, including epithelial ovarian tumors. Our study carefully contrasted the expression of VASH1 in pancancer and nontumorous tissues in a public database to explore its regulatory role in clinical prognosis, diagnosis, tumor purity, and immune cell infiltration. Next, we explored the antitumor mechanism of VASH1 through drug sensitivity, functional enrichment, and phenotypic experiments in ovarian cancer. Research suggests that the expression of VASH1 in neoplastic tissues is lower than that in normal tissues. VASH1 affects the OS and RFS of several tumor types. In addition, V
SUBMITTER: Li Y
PROVIDER: S-EPMC10783835 | biostudies-literature | 2023 Dec
REPOSITORIES: biostudies-literature
ACCESS DATA